mesalamine has been researched along with Stevens-Johnson Syndrome in 5 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "MMX mesalamine was the causative agent by drug-induced lymphocyte stimulation test." | 5.72 | A Case of Stevens-Johnson Syndrome Complicated with Multimatrix System Mesalamine in Ulcerative Colitis. ( Abe, K; Goda, K; Irisawa, A; Kanamori, A; Kanazawa, M; Masuyama, S; Tanaka, T; Tominaga, K; Watanabe, S; Yamamiya, A, 2022) |
| "MMX mesalamine was the causative agent by drug-induced lymphocyte stimulation test." | 1.72 | A Case of Stevens-Johnson Syndrome Complicated with Multimatrix System Mesalamine in Ulcerative Colitis. ( Abe, K; Goda, K; Irisawa, A; Kanamori, A; Kanazawa, M; Masuyama, S; Tanaka, T; Tominaga, K; Watanabe, S; Yamamiya, A, 2022) |
| "Sulfasalazine is an important therapeutic agent in the management of chronic inflammatory bowel disease (CIBD)." | 1.28 | Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease. ( Tolia, V, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanazawa, M | 1 |
| Tominaga, K | 1 |
| Kanamori, A | 1 |
| Tanaka, T | 1 |
| Masuyama, S | 1 |
| Watanabe, S | 1 |
| Abe, K | 1 |
| Yamamiya, A | 1 |
| Goda, K | 1 |
| Irisawa, A | 1 |
| Núñez Ortiz, A | 1 |
| Trigo Salado, C | 1 |
| de la Cruz Ramírez, MD | 1 |
| Herrera Justiniano, JM | 1 |
| Leo Carnerero, E | 1 |
| Iemoli, E | 1 |
| Piconi, S | 1 |
| Ardizzone, S | 1 |
| Bianchi Porro, G | 1 |
| Raimond, F | 1 |
| Fukunaga, K | 1 |
| Ohda, Y | 1 |
| Inoue, T | 1 |
| Kono, T | 1 |
| Miwa, H | 1 |
| Matsumoto, T | 1 |
| Tolia, V | 1 |
5 other studies available for mesalamine and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
A Case of Stevens-Johnson Syndrome Complicated with Multimatrix System Mesalamine in Ulcerative Colitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Male; Mesalamine; Remis | 2022 |
Topical mesalazine as a cause of Stevens-Johnson syndrome.
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Mesalamine; Middle | 2018 |
Erythroderma and toxic epidermal necrolysis caused by to 5-aminosalacylic acid.
Topics: Colitis, Ulcerative; Dermatitis, Exfoliative; Exanthema; Humans; Male; Mesalamine; Stevens-Johnson S | 2006 |
Toxic epidermal necrosis associated with mesalamine in a patient with ulcerative colitis.
Topics: Adolescent; Anti-Inflammatory Agents; Colitis, Ulcerative; Humans; Male; Mesalamine; Stevens-Johnson | 2007 |
Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease.
Topics: Adolescent; Aminosalicylic Acids; Child; Chronic Disease; Desensitization, Immunologic; Diarrhea; Do | 1992 |